🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Why Do Teladoc Health Investors Stand Divided? Bank Of America Analyst Weighs In

Published 11/07/2022, 17:00
Updated 11/07/2022, 17:40
© Reuters.  Why Do Teladoc Health Investors Stand Divided? Bank Of America Analyst Weighs In
BAC
-
TDOC
-
T2DH34
-

On July 10, Bank of America Corp (NYSE: NYSE:BAC) analyst Allen Lutz published an analyst note on Teladoc Health, Inc (NYSE: TDOC).

What Happened: The Bank of America analyst had a Neutral rating on Teladoc with a $42 price objective. Lutz’s analysis came after the company released two new data points and its second-quarter model assumptions.

Information to Know: The first data point was related to a branch of Teladoc Health, Livongo. This area focused on creating new technologies to advance the way patients experience telehealth and in-home health care. Livongo has several large contracts expected to go live in the second half of 2022, according to Lutz.

In addition, there was a report that the number of new downloads for Livongo’s app slowed down at the start of July, but Lutz remains unfazed as it was expected for the holiday weekend.

The second data point is related to BetterHelp and the future of online therapy during the recession. According to a cost of therapy survey conducted by Verywell Mind, 31% of respondents shared that they had paused their mental health services. Respondents shared they felt it was more important to “save money for other, larger expenses” amid a possible recession.

While this survey could seem alarming for the industry, it ran counter to BetterHelp’s uptick in subscribers. The online therapy service remains at a low cost and although not immune to the recession, the company should stay unfazed during this time period.

The Teladoc Bull Case: The bulls believe that Teladoc is in a strong position to succeed in the second quarter. If Livongo can continue to increase consumer confidence and BetterHelp can improve cost trends, then the company will be in a financially strong position. If these trends exist, then the stock will trade at around 20x EBITDA with a 20% revenue growth for the next two years. Lutz also noted that if Teladoc has a strong quarterly report then 20x EBITDA is too low of an expectation for the share price.

The Teladoc Bear Case: The bears worry advertising rates are structurally higher following Apple Inc (NASDAQ: NASDAQ:AAPL) privacy changes and it will not be followed by a rapid reduction in search/social media costs. Bears also noted a disconnect between Sensor Tower’s credit card data which could cause a growth in subscriptions to be muted. This could be caused by BetterHelp’s partnership with singer Justin Bieber. In addition, bears also flag a possible decrease in revenue for BetterHelp amid a possible U.S. recession.

Photo: Teledoc

Latest Ratings for TDOC

DateFirmActionFromTo
Mar 2022Piper SandlerMaintainsOverweight
Mar 2022UBSMaintainsNeutral
Mar 2022Argus ResearchUpgradesHoldBuy
View More Analyst Ratings for TDOC

View the Latest Analyst Ratings

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.